Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Lohray et a].
(54)
US 8,053,579 B2
*Nov. 8, 2011
6,635,763 B2
6,767,913 B2
2002/0177712 A1
2005/0203122 A1
Zoos/0256152 A1
11/2005 Doser et a1
2006/0264636 A1
2007/0037 842 Al
2007/0082924 A1
2009/0270448 A1
(*)
Notice:
1900358
3/2008
WO
2004/013147
2/2004
WO
WO
2004/072084
2004/072085
8/2004
8/2004
WO
2004/074215
9/2004
Clalmer'
(22)
Flled'
Apr 14 2010
(65)
(1982).
Us 2010/0197923 A1
Aug. 5, 2010
28:193-200 (1995).
(63)
OTHER PUBLICATIONS
_
.
Doser et al.
(21)
9/2005
Rosenberg, Patent Law Basics, West Group pp. 9-58 and 9-59 (2000).
s
-
(30)
Rosenberg, Patent Law Basics, West Group pp. 9-62 and 9-63 (2000).
-
Rosenberg, Patent Law Basics, West Group pp. 9-30 and 9-31 (2000).
Apr' 25 2003
(51)
Int Cl
(52)
(58)
C07D 513/02
P rzmar
y Exammer
* AndreW D Kosar
546/114
(56)
References Cited
U.S. PATENT DOCUMENTS
4,529,596 A
4,847,265 A
6,429,210 B1
6,509,348 B1
1/2003 Ogletree
57
( )
ABSTRACT
US. Patent
i(ntcepsif)y 800
Nov. 8, 2011
Sheet 1 015
US 8,053,579 B2
US. Patent
Nov. 8, 2011
Sheet 2 of5
US 8,053,579 B2
mo d?
.w35mg
T[8%
68m
H
_
Mk
m
u
W:25",
mo d.
A@m3z g
(0 w
lo m?
m
o
US. Patent
Nov. 8, 2011
Sheet 3 of5
US 8,053,579 B2
Onset = 124.397 C
4 0.
0.
05.
41.5
mp5
60
50
1CD
140
1 60
Tsmpemiure ("(2)
Figura 3.
16D
20D
240
243i
US. Patent
Nov. 8, 2011
Sheet 4 of5
US 8,053,579 B2
Eswma
8%
?$m3a.u2v5 saw
US. Patent
..4. WWW.
Nov. 8,2011
Sheet 5 of5
US 8,053,579 B2
40. 60
TH...
30.60
{Inctepsit}y 860
600-
US 8,053,579 B2
1
US. Pat. No. 4,847,265 describes the process for the prepa
tion.
FIELD OF INVENTION
(I)
o
ocH3
n H
01
45
forms.
(I1)
60
65
US 8,053,579 B2
4
of 60 C.-70 C.
DESCRIPTION OF FIGURES
EXAMPLE 1
FIG. 1:
FIG. 2:
FIG. 3:
FIG. 4:
FIG. 5:
DETAILED DESCRIPTION
20
tosylate.
m.p.: 75-93 C. (soften)
25
XRD: Amorphous
DSC: No melting peak
% Water: 0.5-4% by Weight (obtained in different batches).
(111)
ocH3
EXAMPLE 2
\\H
0 6
NH
\ -Rso3
01
35
XRD: Amorphous
DSC: No melting peak
% Water: 0.5-4% by Weight (obtained in different batches).
40
EXAMPLE 3
45
6,635,763.
55
60
EXAMPLE 4
Form
65
US 8,053,579 B2
5
EXAMPLE 8
tion.
EXPERIMENT 5
Form
Clopidogrel base Was dissolved in acetone to obtain a clear
solution. Then benZenesulfonic acid Was added to the solu
tion at 200 C. The reaction mixture Was heated to re?ux
temperature for 2 to 10 hrs. The solvent Was evaporated to
dryness under reduced pressure to obtain the title salt as a
poWder.
tion.
20
EXAMPLE 9
XRD: Amorphous
DSC: No melting peaks
% Water: 0.5 -4% by Weight, (obtained in different batches).
XRD: Crystalline
EXAMPLE 6
DSC: l27.5-l32.9 C.
35
EXAMPLE 10
XRD: Amorphous
DSC: No melting peak
% Water: 0.5-4% by Weight (obtained in different batches).
XRD: Crystalline
EXAMPLE 7
DSC: l25.5-l30.9 C.
55
EXAMPLE 11
60
Form
nitrile and other similar solvents either alone or as a mixture 65 C. To this Was added benZene sulphonic acid dissolved in
diethyl ether. The reaction mixture Was stirred at 25 -30 C. for
of tWo or more solvents described elseWhere in the speci?ca
tion.
US 8,053,579 B2
7
XRD: Crystalline
DSC: 128.9-132.7 C.
% Water: 0.2%
We claim:
EXAMPLE 12
124-1340 C.
XRD: Amorphous
DSC: No melting peak
% Water: 0.5-4% by Weight (obtained from different
solvents;
25
batches).
30
Form
XRD: Amorphous
DSC: No melting peak
% Water: 0.5-4% by Weight. (obtained from different
EXAMPLE 13
Water by Weight.
4. A process for preparing crystalline non-solvated Clopi
dogrel besylate as claimed in claim 1, comprising:
Clopidogrel besylate.
7. The process as claimed in claim 6, Wherein the one or
more solvents are selected the group consisting of Water,
batches).
Similarly, the same salt Was prepared in THE, acetonitrile
and other similar solvents either alone or as a mixture of tWo 45 Wherein each alkyl radical of the ether is independently